A Hypersensitive Estrogen Receptor-α Mutation in Premalignant breast Lesions1

Cancer Research

Volumn 60, Issue 15, 2000, Pages 4026-4029

  Fuqua, S A W ^a   Wiltschke, C ^a   Zhang, Q X ^a   Borg, A ^a   Castles, C G ^a   Friedrichs, W E ^a   Hopp, T ^a   Hilsenbeck, S ^a   Mohsin, S ^a   O'Connell, P ^a   Allred, D C ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; ESTROGEN RECEPTOR;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CELL STRAIN MCF 7; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BREAST; BREAST NEOPLASMS; CELL DIVISION; DNA; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; HUMANS; HYPERPLASIA; MUTATION; PRECANCEROUS CONDITIONS; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 0033898141     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. The multistep mature of cancer
2. Risk factors for breast cancer in women with proliferative breast disease
3. Loss-of-heterozygosity in precursor lesions of breast cancer
4. Differential expression of estrogen, progesterone, and epidermal growth factor receptors in normal, benign, and malignant human breast tissue using dual staining immunohistochemistry
5. Loss of heterozygosity at D145S62 and metastatic potential of breast cancer
6. Sequence and expression of human estrogen receptor complementary DNA
7. A variant human breast tumor estrogen receptor with constitutive transcriptional activity
8. A role for estrogen receptor variants in endocrine resistance
9. Heat shock protein 27 is correlated with growth and drug resistance in human breast cancer cells
10. Analysis of transformations
11. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): Multiple motifs with different binding specificities
12. A highly conserved region in the hormone-binding domain of the human estrogen receptor functions as an efficient transactivation domain in yeast
13. Loss of heterozygosity in normal tissue adjacent to breast carcinomas
14. Nuclear receptor coactivators and corepressors
15. The partial agonist activity of antagonist occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT
16. The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1(AFI) and AF2 domains of steroid receptors
17. TIF-2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors
18. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
19. Ligand-independent activation of the estrogen receptors α and β by mutations of a conserved tyrosine can be abolished by antiestrogens
20. An estrogen receptor mutant with strong hormone-independent activity from a metastatic breast cancer